V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006567 | 330011587 | null | null | Curative (C) | 2013-09-25 | 2013-09-30 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330002623 | CISPLATIN + RT |
| 330006568 | 330012331 | null | 84 | Curative (C) | null | 2013-06-20 | CISPLATIN + RT | 02 | Y | 330002628 | CISPLATIN + RT |
| 330006569 | 330007770 | null | 11.1 | Curative (C) | 2014-04-19 | 2014-07-11 | NB HRNBL-1 COJEC Ind COURSE C | Y | N | 330002628 | NOT MATCHED |
| 330006570 | 330003326 | 0 | 64.6 | Curative (C) | 2016-05-16 | 2016-05-19 | NB HRNBL-1 Isotretinoin | N | Y | 330002637 | NOT MATCHED |
| 330006571 | 330010233 | 1.69 | null | Curative (C) | 2014-11-28 | 2014-12-14 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330002645 | CISPLATIN + RT |
| 330006575 | 330003328 | 0 | null | Curative (C) | 2013-06-29 | 2013-06-29 | CISPLATIN + RT | 02 | N | 330002670 | CISPLATIN + RT |
| 330006576 | 330003329 | 1.76 | 99.7 | Curative (C) | 2014-12-21 | 2015-05-17 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 330002671 | CISPLATIN + RT |
| 330006578 | 330003330 | 0.98 | 55 | Curative (C) | 2016-06-15 | 2016-06-23 | NB HRNBL-1 COJEC Ind COURSE A | 2 | N | 330002686 | NOT MATCHED |
| 330006579 | 330003331 | 1.66 | 63.25 | Curative (C) | 2014-12-13 | 2014-12-13 | Cisplatin + Radiotherapy | null | Y | 330002704 | CISPLATIN + RT |
| 330006580 | 330003331 | 1.57 | 12 | Curative (C) | 2015-08-30 | 2015-12-24 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | 330002704 | NOT MATCHED |
| 330006581 | 330010235 | 1.13 | 11.5 | Curative (C) | 2014-06-22 | 2014-07-08 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330002705 | NOT MATCHED |
| 330006582 | 330007776 | 1.74 | 92 | Curative (C) | null | 2015-03-16 | Cisplatin + Radiotherapy | null | null | 330002709 | CISPLATIN + RT |
| 330006583 | 330003333 | 1.61 | 67.25 | Curative (C) | 2015-01-23 | 2015-01-23 | Cisplatin + Radiotherapy | N | Y | 330002716 | CISPLATIN + RT |
| 330006584 | 330003333 | 1.59 | 119 | Curative (C) | 2015-03-29 | 2015-03-29 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 330002716 | CISPLATIN + RT |
| 330006585 | 330010236 | 1.73 | 51.8 | Curative (C) | 2016-12-28 | 2017-01-25 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 330002728 | CISPLATIN + RT |
| 330006586 | 330003334 | 0 | 36.9 | Palliative (P) | 2014-07-06 | 2014-07-23 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330002732 | NOT MATCHED |
| 330006587 | 330003334 | 0 | 10.7 | Curative (C) | 2015-04-03 | 2015-04-15 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | N | N | 330002732 | NOT MATCHED |
| 330006588 | 330003336 | 1.71 | 73.4 | Curative (C) | 2017-07-18 | 2017-07-18 | CISPLATIN + RT | N | Y | 330002736 | CISPLATIN + RT |
| 330006589 | 330007779 | 1.6 | 8.5 | null | 2015-05-25 | 2015-06-21 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | 330002743 | NOT MATCHED |
| 330006590 | 330003338 | 0 | 73 | Curative (C) | 2015-04-30 | 2015-05-19 | NB HRNBL-1 Isotretinoin | 02 | N | 330002745 | NOT MATCHED |
| 330006591 | 330003339 | 0 | 8 | Curative (C) | 2016-12-21 | 2017-01-10 | NB HRNBL-1 BUMEL MAT | N | N | 330002747 | NOT MATCHED |
| 330006592 | 330003340 | 1.74 | 50.9 | Curative (C) | 2017-06-25 | 2017-07-16 | CISPLATIN + RT | N | Y | 330002747 | CISPLATIN + RT |
| 330006593 | 330003341 | 1.63 | null | Curative (C) | 2016-07-24 | 2016-08-25 | Cisplatin + Radiotherapy | 02 | Y | 330002762 | CISPLATIN + RT |
| 330006594 | 330003342 | null | 12.8 | Neo-adjuvant (N) | 2013-10-09 | 2014-03-27 | NB HRNBL-1 BUMEL MAT | N | N | 330002765 | NOT MATCHED |
| 330006595 | 330007782 | null | 12.7 | Curative (C) | 2016-12-04 | 2016-12-12 | NB HRNBL-1 ch14.18/CHO only (trial) | 2 | N | 330002779 | NOT MATCHED |
| 330006596 | 330003343 | null | 19.2 | Curative (C) | 2016-09-01 | 2016-09-06 | NB HRNBL-1 Isotretinoin | N | N | 330002800 | NOT MATCHED |
| 330006597 | 330003344 | 0 | 17.2 | Adjuvant (A) | 2013-04-08 | 2013-04-08 | EW EuroEwing 2012 Arm B VC | N | N | 330002800 | NOT MATCHED |
| 330006598 | 330003344 | null | 12.1 | Neo-adjuvant (N) | 2014-10-08 | 2014-11-06 | CNS LGG 2004 03 cons vinc + carbo | 02 | N | 330002800 | NOT MATCHED |
| 330006599 | 330003346 | 1.56 | 36.35 | Palliative (P) | 2013-04-09 | 2013-04-09 | CNS GCT II Germinoma - Ifos Etop | N | N | 330002811 | NOT MATCHED |
| 330006600 | 330003346 | null | 9.7 | Palliative (P) | 2017-01-10 | 2017-01-16 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330002811 | NOT MATCHED |
| 330006601 | 330003348 | 1.66 | null | Curative (C) | 2018-03-30 | 2018-03-30 | Cisplatin + Radiotherapy | 02 | Y | 330002818 | CISPLATIN + RT |
| 330006603 | 330003349 | null | 16.2 | Curative (C) | 2014-04-08 | 2014-04-17 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | N | N | 330002822 | NOT MATCHED |
| 330006604 | 330003350 | 1.13 | 8.5 | Palliative (P) | 2018-03-02 | 2018-04-01 | null | N | N | 330002829 | NOT MATCHED |
| 330006605 | 330003351 | 1.83 | null | Curative (C) | 2014-02-11 | 2014-03-05 | CISPLATIN + RT | 02 | Y | 330002830 | CISPLATIN + RT |
| 330006606 | 330003352 | null | 52 | Adjuvant (A) | 2016-01-22 | 2016-05-06 | NB HRNBL-1 ch14.18/CHO only (trial) | null | N | 330002835 | NOT MATCHED |
| 330006607 | 330003354 | null | 86.05 | null | 2016-02-17 | 2016-03-02 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | 330002838 | NOT MATCHED |
| 330006608 | 330003356 | null | 194 | Curative (C) | 2013-08-13 | 2013-08-13 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330002843 | CISPLATIN + RT |
| 330006609 | 330003356 | null | 13.7 | null | 2017-02-08 | 2017-02-08 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330002843 | NOT MATCHED |
| 330006610 | 330003357 | 0 | 14.4 | Curative (C) | 2016-08-20 | 2016-08-20 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330002844 | NOT MATCHED |
| 330006611 | 330003358 | null | 53.75 | Adjuvant (A) | 2016-02-05 | 2016-02-05 | Cisplatin + Radiotherapy | 02 | Y | 330002858 | CISPLATIN + RT |
| 330006612 | 330003359 | 0 | 10.9 | Curative (C) | 2016-04-29 | 2016-07-03 | NB Rel CCLG guidelines Irin & Temoz | 02 | N | 330002870 | NOT MATCHED |
| 330006613 | 330003359 | 1.82 | 96 | Not known (9) | 2016-10-14 | 2016-12-22 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330002870 | CISPLATIN + RT |
| 330006614 | 330003360 | 1.89 | 72.6 | Curative (C) | 2014-03-26 | 2014-03-26 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330002875 | CISPLATIN + RT |
| 330006615 | 330003361 | 1.71 | 66.8 | Curative (C) | 2015-12-25 | 2015-12-25 | CISPLATIN + RT | 02 | N | 330002876 | CISPLATIN + RT |
| 330006616 | 330003362 | null | 98 | Palliative (P) | 2015-12-07 | 2016-03-11 | EW EuroEwing 2012 Arm B VC | N | null | 330002879 | NOT MATCHED |
| 330006617 | 330003364 | null | 85.8 | Curative (C) | null | 2015-02-27 | BLEOMYCIN + CISPLATIN + PACLITAXEL | 1 | N | 330002884 | NOT MATCHED |
| 330006618 | 330003366 | null | 77 | Adjuvant (A) | null | 2017-12-01 | Cisplatin 100 + RT(H&N) 1 day | null | null | 330002884 | CISPLATIN + RT |
| 330006619 | 330010244 | 1.72 | 73.7 | Curative (C) | 2014-10-16 | 2014-10-25 | CISPLATIN + RT | 2 | null | 330002895 | CISPLATIN + RT |
| 330006620 | 330003367 | 1.66 | 88.8 | Curative (C) | 2014-11-13 | 2014-11-14 | CISPLATIN + RT | 02 | null | 330002898 | CISPLATIN + RT |
| 330006621 | 330003368 | 1.85 | 18.1 | Curative (C) | 2014-03-30 | 2014-07-24 | NB HRNBL-1 COJEC Ind COURSE A | 2 | Y | 330002900 | NOT MATCHED |